MEDMIRA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.075 CAD | 0.00% |
|
0.00% | -31.82% |
| Apr. 02 | MedMira Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024 | CI |
| Mar. 27 | Samsung Pay to stop working with Russia's Mir payment system from April 3 | RE |
Valuation
| Fiscal Period: July | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 9.875 | 6.584 | 276.5 | 79.37 | 87.18 | 59.28 |
| Enterprise Value (EV) 1 | 17.46 | 15.1 | 288 | 90.9 | 95.95 | 69.32 |
| P/E ratio | -3.75 x | -3.13 x | -135 x | -117 x | -41.7 x | -21.3 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 16.8 x | 12.5 x | 301 x | 37 x | 91.6 x | 137 x |
| EV / Revenue | 29.6 x | 28.6 x | 313 x | 42.4 x | 101 x | 160 x |
| EV / EBITDA | -9.84 x | -11.8 x | -223 x | -568 x | -67.4 x | -36.2 x |
| EV / FCF | 418 x | -109 x | 797 x | -234 x | -51.8 x | -191 x |
| FCF Yield | 0.24% | -0.92% | 0.13% | -0.43% | -1.93% | -0.52% |
| Price to Book | -0.87 x | -0.49 x | -17.8 x | -5.05 x | -7.05 x | -3.94 x |
| Nbr of stocks (in thousands) | 658,364 | 658,364 | 658,364 | 661,376 | 697,446 | 697,446 |
| Reference price 2 | 0.0150 | 0.0100 | 0.4200 | 0.1200 | 0.1250 | 0.0850 |
| Announcement Date | 3/28/19 | 11/28/19 | 11/30/20 | 11/30/21 | 11/29/22 | 11/28/23 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: July | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.5889 | 0.5274 | 0.9191 | 2.144 | 0.9521 | 0.4325 |
| EBITDA 1 | -1.774 | -1.277 | -1.291 | -0.16 | -1.424 | -1.915 |
| EBIT 1 | -1.84 | -1.296 | -1.3 | -0.1842 | -1.453 | -1.944 |
| Operating Margin | -312.51% | -245.72% | -141.46% | -8.59% | -152.63% | -449.52% |
| Earnings before Tax (EBT) 1 | -2.509 | -2.106 | -2.045 | -0.6758 | -1.832 | -2.676 |
| Net income 1 | -2.509 | -2.106 | -2.045 | -0.6758 | -1.832 | -2.676 |
| Net margin | -426.15% | -399.37% | -222.55% | -31.51% | -192.37% | -618.61% |
| EPS 2 | -0.003999 | -0.003199 | -0.003106 | -0.001026 | -0.002999 | -0.004000 |
| Free Cash Flow 1 | 0.0418 | -0.1387 | 0.3615 | -0.3888 | -1.851 | -0.362 |
| FCF margin | 7.1% | -26.3% | 39.33% | -18.13% | -194.42% | -83.7% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/28/19 | 11/28/19 | 11/30/20 | 11/30/21 | 11/29/22 | 11/28/23 |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: July | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 7.58 | 8.52 | 11.5 | 11.5 | 8.77 | 10 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | -4.276 x | -6.672 x | -8.918 x | -72.11 x | -6.154 x | -5.24 x |
| Free Cash Flow 1 | 0.04 | -0.14 | 0.36 | -0.39 | -1.85 | -0.36 |
| ROE (net income / shareholders' equity) | 24.6% | 16.9% | 14.1% | 4.32% | 13% | 19.5% |
| ROA (Net income/ Total Assets) | -236% | -293% | -44.5% | -3.16% | -23.5% | -32.5% |
| Assets 1 | 1.063 | 0.7196 | 4.592 | 21.38 | 7.784 | 8.236 |
| Book Value Per Share 2 | -0.0200 | -0.0200 | -0.0200 | -0.0200 | -0.0200 | -0.0200 |
| Cash Flow per Share | - | 0 | 0 | - | 0 | 0 |
| Capex 1 | 0 | - | 0.1 | 0.04 | 0.07 | 0 |
| Capex / Sales | 0.57% | - | 11.09% | 1.7% | 7.32% | 0.29% |
| Announcement Date | 3/28/19 | 11/28/19 | 11/30/20 | 11/30/21 | 11/29/22 | 11/28/23 |
1CAD in Million2CAD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -31.82% | 38.45M | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
- Stock Market
- Equities
- MIR Stock
- Financials MedMira Inc.
